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We have observed that different gelatins exhibit diffe­
rent biological activities. Bovine bone (BB) gelatin stimu­
lated proliferation of murine spleen cells in vitro [1]. BB and 
porcine skin (PS) gelatins stimulated murine peritoneal 
macrophages (mPMs) to secrete several cyokines, e.g., 
interleukin (IL)­6, ­12, TNF­α and MCP­1 [2]. Alternatively 
PS gelatin suppressed proliferation of cells of human as 
well as murine cell lines [1, 3, 4]. In this study, we investi­
gated whether or not PS gelatin induced anti­tumor activity 
of mPMs. There are many reports about stimulants that 
induce anti­tumor activity of macrophages. Mantovani [5] 
described that activated mononuclear phagocytes killed 
transformed target cells via different mediators, e. g., 
cyto kines (IL­1 [6], TNF [7], IL­6 [8]), reactive intermedi­
ates of oxygen [9], or nitrogen [10]. It was documented 
that neutral serine protease [11] secreted by activated 
macrophages was involved in the effector function. The 
present study demonstrated that PS gelatin induced anti­
tumor activity of mPMs and that its mechanism was mostly 
different from all described above.
MATERIALS AND METHODS
Mice. Five to eight week­old female C3H/HeN and 
C3H/HeJ mice were purchased from Chubu Kagaku 
Shizai Co. Ltd. (Nagoya, Japan). All the experiments 
were performed accoding to the approved animal­care 
protocols of the Ethical Committee of institution.
Cell Lines. A murine hepatic cell carcinoma cell line, 
MH134, a murine fibrosarcoma cell line, Meth A and 
a murine T cell lymphoma cell line, BW5147 have been 
maintained in suspension culture in our laboratory.
Reagents. PS gelatin and Interferon­γ(IFN­γ) 
were purchased from Sigma Chemical Co. (St. Louis, 
MO, USA). Lipopolysaccharide (LPS) derived from 
E. coli 026: B6 was purchased from Difco Laboratories 
(Detroit, MI, USA). Anti­mouse TNF­α antibody was 
purchased from upstate biotechnology (Lake Placid, 
NY 12946, USA).
Peritoneal exudate cells. A mouse was injected 
with 3 ml of 3% thioglycollate medium (Sigma Chemical 
Co.) intraperitoneally (i.p.). Three days after, about 8 ml of 
physiological buffered saline (PBS) was injected into the 
peritoneal cavity and the PBS containing peritoneal exu­
date cells (PECs) was aspirated. PECs were washed with 
modified MEM twice. Modified MEM was composed of 
2 mM L­glutamine, 5 x 10­5 M 2­mercaptoethanol, 25 mM 
HEPES and Eagle’s minimum essential medium(Nissui 
Pharmaceutical Co. Ltd., Tokyo, Japan).
In vitro anti-tumor activity assay using tritium 
thymidine. PECs (1 x 105/well) were incubated in wells 
of a 96­well round­bottomed microtiter plate, each 
containing 0.1 ml of 10% FCS modified MEM at 37 °C 
for 90 min. The PECs equally adhered to the round 
bottoms, which was confirmed microscopically. The 
adherent PECs were used as mPMs. In the preliminary 
experiment using a kit, CytoTox 96® Non­radioactive 
Cytotoxicity Assay (Promega, Woods, Hollow Road 
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Madison, WI, USA), the amount of LDH released from 
1 x 105 of lysed PECs was similar to that of the lysed 
adherent population of 1 x 105 of PECs. It showed 
that the number of adherent PECs approximated that 
of PECs. In order to easily wash non­adherent target 
cells by centrifugation, round­bottomed microtiter 
plates were used. Non­adherent target cells equally 
settled on the round bottoms when the plate was not 
centrifuged. mPMs (approximately 1 x 105/well) were 
incubated with reagents in the wells, each containing 
0.2 ml of 5% FCS modified MEM at 37 °C for 24 h. 
After washing the wells with PBS twice, target cells 
(5 x 103/well) were added to the wells, each contai­
ning 0.2 ml of 5% FCS modified MEM followed by an 
additional 48 h incubation. Tritium thymidine (3H­TdR) 
was added to all wells (final concentration: 1 μCi/ml) 
approximately 7 h before the termination of the incu­
bation. Thereafter they were washed with 0.2 ml of 
PBS twice and mixed with 0.2 ml of 1% sodium lauryl 
sulfate, and 0.1 ml of the 0.2 ml was mixed with 3 ml 
of a scintillator (Ready Flow III, Beckman). Scintillation 
of the mixture was counted with a scintillation counter 
(Beckman LS3801). When target cells were incubated 
with effector cells, 3H­TdR uptake by the target cells 
was calculated by subtracting 3H­TdR uptake by effec­
tor cells from that by both effector and target cells.
Culture supernatants of mPMs incubated with 
a stimulant. mPMs (1 x 106/well) were incubated 
with or without 15 mg/ml of PS gelatin or 500 ng/ml 
of LPS in wells of a 24­well culture plate, each contai­
ning 2 ml of 5% FCS modified MEM at 37 °C for 24 h. 
After washing the cells, they were incubated in 2 ml 
of 5% FCS modified MEM at 37 °C for 24 h. Then the 
supernatants were collected and stored at –20 °C until 
used for anti­tumor assay or cytokine detection as­
say. Target cells (5 x 103/well) were incubated in wells 
of a 96­well round­bottomed microtiter plate, each 
containing 50 μl of 5% FCS modified MEM and the 
supernatant (150 μl) at 37 °C for 48 h. The manner of 
pulse by 3H­TdR was described above.
Ultrafiltration. The supernatant was filtered with 
centrifugal filter devices, models YM­10 at 14 000 g 
for 30 min (Millipore Corporation, Bedford, MA, USA) 
and filtrates and retentates were reconstituted with the 
original medium. The membrane nominal molecular 
weight limit of YM­10 is 10 000 in Daltons.
Fluorescent immunohistochemistry. The cell 
samples were fixed with 4% formaldehyde solution in 
phosphate buffered saline (PBS) for 15 min at room 
temperature. Then, they were washed three times with 
PBS, after which incubated with 0.1% Triton X­100 in 
PBS for 5 min at room temperature. Then they were in­
cubated 10% normal goat serum (NGS) in PBS at room 
temperature for 30 min to block non­specific binding. 
Further they were incubated with optimum concentra­
tions of primary antibody diluted with 10% NGS in PBS 
for 60 min at room temperature. As primary antibody, 
rabbit polyclonal antibody against asialo GM1 (natural 
killer cell marker) and rat anti­mouse F4/80 (IgG2b) 
(macrophage marker) were obtained from Wako Pure 
Chemical Industries, Ltd. (Osaka, Japan) and AbD 
Serotec (Oxford, UK), respectively. All antibodies were 
labeled using Zenon Labeling Kits (Molecular Probes, 
OR, USA). The cells and polyclonal antibodies were 
observed using an immunofluorescence microscope 
(Axio Observer. Z1; Zeiss, Oberkochen, Germany) with 
a magnification of x100 and a halogen lamp of 100 W. 
Images were photographed using a digital camera 
(AioCam MRm, HRc; Zeiss) and AxioVision 4.6 soft­
ware (Zeiss). The photographs made with 4 different 
filters were later merged with the AxioVision 4.6 soft­
ware to get the quadruple­stained pictures.
Statistics. Difference between 2 groups was 
evaluated using Student’s t­test. Difference between 
2 groups in tumor sizes was evaluated using Mann­
Whitney test because each population of tumor size 
did not show statistic normal distribution. Difference 
between 2 groups in survival was evaluated using 
generalized Wilcoxon test. p values of 5% or less were 
considered statistically significant.
RESULTS
Comparison of PS gelatin with LPS in inducing 
anti-tumor activities of mPMs. Fig. 1 shows that 
mPMs incubated with PS gelatin exerted anti­tumor 
activity at effector : target ratio (ET ratio) 2, which 
was statistically significant (p < 0.05). On the other 
hand, mPMs intact or incubated with LPS enhanced 
proliferation of target cells at ET ratio 1~2. Intact 
mPMs exerted anti­tumor activity at ET ratio 16. mPMs 
incubated with LPS exerted anti­tumor activity at ET 
ratio 8. LPS of 500 ng/ml was optimal in stimulating 
cytokine secretion and 15 mg/ml of PS gelatin also 
optimal in suppressing tumor cell proliferation (data 
not shown).
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Fig. 1. Comparison between LPS and PS gelatin in induction 
of anti­tumor activities in mPMs. mPMs were incubated with 
500 ng/ml of LPS ( ) or 15 mg/ml of PS gelatin ( ) or without 
both ( ) in 5% FCS modified MEM at 37 °C for 24 h. Those mPMs 
were collected with a scraper. Then they or no mPMs ( ) were 
incubated with BW5147 cells at the indicated ET ratio at 37 °C 
for additional 24 h
Induction of anti-tumor activity of mPMs by 
synergistic action of LPS and IFN-γ. Fig. 2 shows 
that mPMs stimulated with 1 ng/ml of IFN­γ to exert 
anti­tumor activity, that as low as 0.1 ng/ml of IFN­γ 
synergistically enhanced anti­tumor activity of mPMs 
with 500 ng/ml of LPS and that 1 ng/ml of IFN­γ ad­
ditionally augmented anti­tumor activity of mPMs with 
10 mg/ml of PS gelatin.
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Fig. 2. Synergistic action of LPS and IFN­γ inducing anti­tumor activi­
ty in mPMs. mPMs were incubated with the indicated concentration of 
IFN­γ in the presence of 500 ng/ml of LPS ( ), 10 mg/ml of PS gelatin 
( ) or absence of both ( ) at 37 °C for 24 h, and those reagents were 
washed out. Then they were incubated with BW5147 cells at 37 °C for 
additional 24 h. *Statistically different from control ( , 0) at p < 0.05.
Anti-Tumor Activity of the Culture Superna-
tant of mPMs Incubated with LPS or PS Gelatin. 
Fig. 3 shows that both supernatants of mPMs incu­
bated with LPS and PS gelatin suppressed 3H­TdR 
uptake by MH134 cells and that the activity of the 
supernatant of mPMs incubated with PS gelatin was 
higher than that with LPS. The supernatant of mPMs 
alone enhanced 3H­TdR uptake by MH134 cells.
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Fig. 3. Anti­tumor activity of culture supernatant of mPMs stimu­
lated by LPS or PS gelatin. mPMs were incubated with or without 
(None) 15 mg/ml of PS gelatin (PS) or 500 ng/ml of LPS (LPS) in 
5% FCS modified MEM at 37 °C for 24 h. After discarding stimula­
tors, they were incubated in the new medium at 37 °C for additional 
24 h. The supernatants were collected. MH134 cells were incu­
bated in 150 μl of the supernatant and 50 μl of 5% FCS modified 
MEM (closed) or in 200 μl of the medium alone (opened) at 37 °C 
for 48 h. *Statistically different from LPS at p < 0.01.
Molecular size of the factor having the anti-
tumor activity in the culture supernatant. The filter 
which does not pass molecules of more than 10 kDa 
suggested that the molecular weight of the anti­tumor 
activity was over 10 kDa (Fig. 4).
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Fig. 4. Molecular size of the factor having the anti­tumor activi­
ty in the culture supernatant. The culture supernatant of mPMs 
with or without (black) 15 g/ml of PS gelatin (white) or 500 ng/ml 
of LPS (grey) was ultrafiltered with microcon YM­10 (10 kDa). 
*Statistically different from control (black) at p < 0.01.
IL-1β, IL-6, TNF-α and IFN-γ in the culture 
supernatant of mPMs incubated with LPS or PS 
gelatin. In the experiment shown in Fig. 5, the anti­
tumor activity of the supernatant of mPMs incubated 
with PS gelatin or LPS was examined. In this experi­
ment, concentrations of anti­tumor cytokines, i. e., 
IL­1β, IL­6, TNF­α and IFN­γ in those supernatants 
were measured. Fig. 5 shows that LPS was more ex­
cellent than PS gelatin in stimulating mPMs to secrete 
cytokines (IL­1β, IL­6, TNF­α and IFN­γ).
Effect of anti-TNF-α antibody on the anti-tumor 
activity of the supernatant. Fig. 6 shows that the 
anti­tumor activity of the supernatant of mPMs incu­
bated with PS gelatin was not affected by anti­TNF­α 
antibody, but that with LPS was partially inhibited by 
the antibody.
Involvement of Toll-like receptor 4 in induction 
of anti-tumor activity of mPMs by PS gelatin. Mac­
rophages of C3H/HeJ mice lack Toll­like receptor 4 
(TLR4). Fig. 7 shows that PS gelatin stimulated mPMs of 
both C3H/HeN and /HeJ mice to exert anti­tumor acti­
vity whereas LPS did mPMs of C3H/HeN mice only.
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Fig. 5. IL­1β, IL­6, TNF­α and IFN­γ in culture supernatants of mPMs incubated with LPS or PS gelatin. mPMs were incubated with 
or without (None) 15 mg/ml of PS gelatin (PS) or 500 ng/ml of LPS (LPS) in 5% FCS modified MEM at 37 °C for 24 h. After discarding 
stimulators, they were incubated in the new medium at 37 °C for additional 24 h. Supernatants were collected and the amounts of 
IL­1β (a), IL­6 (b), TNF­α (c) and IFN­γ (d) were measured
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Fig. 6. Effect of anti­TNF­α antibody on the anti­tumor activi­
ty of the culture supernatant. The supernatant (150 μl/well) of 
mPMs incubated with or without (black) 15 mg/ml of PS gelatin 
(white) or 500 ng/ml of LPS (grey) was incubated with or without 
120 ng/ml of anti­mouse TNF­α antibody (25 μl/well) at 37 °C for 
1 h, and Meth A cells (5 x 103/25 μl/well) were added to the wells 
followed by an additional 24 h incubation. *Statistically different 
from control (black) at p < 0.01, **not different.
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Fig. 7. Involvement of TLR 4 in inducing anti­tumor mPMs by PS 
gelatin. mPMs of C3H/HeN or /HeJ were incubated with or without 
(black) 10 mg/ml of PS gelatin (white) or 500 ng/ml of LPS (grey) 
at 37 °C for 24 h. After removing those reagents, MH134 cells were 
incubated with the mPMs for additional 24 h. *Statistically different 
from control (black) at p < 0.05, **not different.
Winn’s test to prove generation of anti-tumor 
mPMs by PS gelatin in vitro. When mPMs incubated 
with PS gelatin in vitro were injected with MH134 cells 
i.p. or subcutaneously (s. c.), tumor­bearers of each 
group survived for longer periods than those injected 
with mPMs incubated in the absence of PS gelatin 
(Fig. 8, a, c) and the subcutaneous tumors grew more 
slowly than those of the control mice (Fig. 8, b).
Effects of PECs, PS gelatin and both on tumor 
growth in vivo. When PECs, PS gelatin or both were 
injecetd with MH134 cells i. p, the survival of each 
group did not differ statistically (Fig. 9, a). On the 
other hand, PS gelatin plus PECs or PS gelatin alone 
suppressed the tumor growth as compared with PECs 
alone when they were injected with MH134 cells s. c. 
(Fig. 9, b) and moreover PS gelatin plus PECs but not 
PS gelatin alone had the tumor­bearers survive for 
a longer period than PECs alone (Fig. 9, c).
Identification of Adherent PECs. Fluorescent 
immunohistochemistry showed that more than 90% 
of adherent PECs was F4/80­positive and at most 10% 
of them was asialo GM1­positive (data not shown).
DISCUSSION
PS gelatin was observed to suppress prolifera­
tion of tumor cells in vitro [2, 3]. However, when PS 
gelatin administered in vivo, it was expected to be 
easily degraded by various proteases, e. g., lysosomal 
enzymes in mPMs. Therefore, the effect of mPMs on 
degradation of PS gelatin was investigated by means of 
in vitro anti­tumor activity of PS gelatin. In this experi­
ment, adherent PECs were regarded as mPMs since 
more than 90% of them had F4/80 antigen. mPMs 
were added to the incubation of tumor cells with PS 
gelatin. If mPMs degrade PS gelatin, the anti­tumor 
activity must be attenuated. Unexpectedly mPMs 
0
10
20
30
40
50
60
70
80
90
100
11 13 15 17 19
Survival (day)
%
 s
ur
vi
va
l
0
50
100
150
200
250
300
350
400
450
18 33 49 62
Day
Tu
m
or
 s
iz
e 
(m
m
 x
 m
m
)
0
10
20
30
40
50
60
70
80
90
100
18 33 49 62
Survival (day)
%
 s
ur
vi
va
l
Fig. 8. Winn’s test to prove the stimu­
lation of mPMs by PS gelatin in vitro. 
mPMs (4 × 106/dish) were incubated 
with ( ) or without ( ) 15 mg/ml of 
PS gelatin in dishes at 37 °C for 48 h. 
Then they were collected with a 
scraper, and mPMs/dish were mixed 
with 1 × 105 of MH134 cells and the 
mixture was inoculated i. p. (a) or 
s. c. (b, c). Both are statistically dif­
ferent at p < 0.05 (a), at p < 0.05 on 
day 18, 26, 33, 38 and 64 (b) and at 
p < 0.01 (c)
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Fig. 9. Effects of PECs, PS gelatin 
and both on tumor growth in vivo. 
PECs (1 × 107) ( ), 25 mg of PS gela­
tin ( ) or both ( ) were inoculated into 
the peritoneal cavity with 5 × 105 of 
MH134 cells (a). PECs (2 × 106) ( ), 
1.75 mg of PS gelatin ( ) or both ( ) 
were inoculated s. c. with 1 × 105 of 
MH134 cells (b, c). Both ( , ) are 
not different from control ( ) statisti­
cally (a) and statistically different from 
control ( ) at p < 0.05 on day 16, 19, 
22 and 26 (b). Both ( , ) are statisti­
cally different at p < 0.05, but both ( , 
) are not different statistically (c)
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augmented the anti­tumor activity of PS gelatin (data 
not shown), and so it was examined whether or not PS 
gelatin stimulated mPMs to be cytostatic or cytocidal in 
the present study. In addition, BB gelatin also became 
to obtain anti­tumor activity in the same experimental 
system whereas it did not exert anti­tumor activity by 
itself (data not shown). This may be related with its ac­
tivity to stimulate mPMs to secrete various cytokines, 
which was greater than that of PS gelatin [2].
mPMs incubated with PS gelatin exerted anti­tumor 
activity in vitro. The experiment using double chamber 
culture indicated that the anti­tumor activity of mPMs 
incubated with PS gelatin did not require the contact 
with target cells (data not shown). However, a possibili­
ty that the contact of target cells with activated mPMs 
exerts an additional anti­tumor effect is not deniable. 
The culture supernatant of mPMs incubated with PS 
gelatin exerted higher anti­tumor activity than that 
with LPS (Fig. 3).
LPS stimulated macrophages [2] or cells of a mac­
rophage cell line [12] to secrete a variety of cytokines 
or an anti­tumor factor other than IL­1β, IL­6 and 
TNF­α, respectively. Previously we reported that PS 
gelatin stimulated mPMs to secrete IL­6, IL­12 and 
TNF­α and other cytokines but its activity was lower 
than that of BB gelatin and by far lower than that of 
LPS [2]. Clarke et al. [13] described that inhibition of 
macrophage­mediated killing was associated with 
decreases in superoxide, nitric oxide and TNF­α pro­
duction in response to provocative stimulus. In this 
study, LPS induced larger amounts of cytokines, i. e., 
IL­1β, IL­6, TNF­α and IFN­γ in mPMs than PS gela­
tin. However, mPMs stimulated by LPS exerted lower 
anti­tumor activity than those stimulated by PS gelatin. 
The anti­tumor activity of the supernatant of mPMs 
stimulated by LPS but not PS gelatin partly depends on 
TNF­α. The ultrafiltration study showed that the active 
molecule did not pass through 10 kDa filter. Therefore 
superoxide or nitric oxide is suggested not to be the 
candidate for the anti­tumor activity of the culture 
supernatants generated by PS gelatin and LPS.
Lorsbach et al. [10] reported that synthesis of NO 
was increased when cells of a mouse macrophage 
cell line, RAW 264.7 were costimulated with LPS and 
IFN­γ. This increase paralleled increase in cytotoxicity. 
In our experiment, the synergism between LPS and 
IFN­γ also was shown in exerting anti­tumor activity 
of mPMs. However, the synergism between IFN­γ and 
PS gelatin was not shown (Fig. 2).
It is well known that LPS stimulates macrophages 
via TLR­4 [13, 14]. Previously we reported that PS gela­
tin as well as LPS stimulated mPMs to secrete TNF­α 
via TLR­4 [2]. In the present study, however, mPMs 
of C3H/HeJ mice (TLR­4 deficient) incubated with 
PS gelatin exerted anti­tumor activity in vitro whereas 
those incubated with LPS did not. This finding sug­
gests that induction of anti­tumor activity in mPMs by 
PS gelatin depends on another pathway than cytokine 
signaling pathway via TLR 4.
The anti­tumor activity of mPMs incubated with PS 
gelatin was exerted in vivo as well as in vitro regardless 
of inoculation site. Miyasaka et al. [15] reported that 
PECs elicited by i.p. inoculation of 3% thioglycollate 
medium exerted anti­tumor activity in vitro but not 
in vivo. The PECs rather increased the number of 
lung metastases when injected with tumor cells intra­
venously. When the mixture of PS gelatin, PECs and 
tumor cells or that of PS gelatin and tumor cells was 
inoculated s. c., the tumor growth was suppressed to 
the same extent in each group as compared with the 
mixture of PECs and tumor cells as control, and the 
survival of the former but not the latter was significantly 
prolonged as compared with the control. These fin­
dings suggest that some immunological mechanism in 
which PECs, especially PECs activated by PS gelatin, 
participated induced the prolonged survival. When the 
mixture of PS gelatin, PECs and tumor cells or that of 
PS gelatin and tumor cells was inoculated i.p., the sur­
vival of tumor bearers was not prolonged. These in vivo 
experiments suggest that the contact of PECs with PS 
gelatin for an appropriate duration in vivo is required for 
their activation and that once they are activated, e.g., 
incubation in vitro, they exert anti­tumor activity also 
in such a large space as peritoneal cavity. PS gelatin 
might disappear rapidly from peritoneal cavity when 
injected i. p., and might remain in situ when injected 
s. c. However, results of this experiment using PECs 
but not adherent PECs cannot exclude involvement of 
natural killer cells since PECs are expected to contain 
more natural killer cells than adherent PECs.
This study using female mice cannot discuss the 
effect of sex.
In conclusion, PS gelatin is a new macrophage 
stimulant and its ability to induce anti­tumor mac­
rophages is higher than that of LPS or IFN­γ. The 
mechanism remains to be clarified. One study is under 
investigation whether or not PS gelatin administered 
repeatedly i. p. would prolong the survival of mice 
bearing MH134 tumor, and another is identifying the 
anti­tumor molecule in the culture supernatant of 
mPMs stimulated by PS gelatin.
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ПРОТИВООПУХОЛЕВАЯ АКТИВНОСТЬ МЫШИНЫХ 
ПЕРИТОНЕАЛЬНЫХ МАКРОФАГОВ, ИНДУЦИРОВАННАЯ 
ЖЕЛАТИНОМ КОЖИ СВИНЬИ
Цель: изучить in vitro противоопухолевую активность мышиных перитонеальных макрофагов, индуцированную желатином 
кожи свиньи. Методы: противоопухолевую активность макрофагов оценивали по включению меченного тимидина опухолевы-
ми клетками-мишенями. Уровень цитокинов, секретируемых в культуральную среду, определяли с помощью ELISA. Результа-
ты: cпособность желатина индуцировать противоопухолевую активность макрофагов была сильнее, чем у липополисахарида 
E. coli. Комбинация липополисахарида и интерферона-γ (IFN-γ) синергично стимулировала макрофаги, что показано и для 
комбинации желатина с IFN-γ. Противоопухолевая активность культурального супернатанта макрофагов, инкубированных 
с желатином, была выше, чем в случае применения липополисахарида, хотя липополисахарид индуцировал более сильную 
секрецию противоопухолевых цитокинов (IL-1, IL-6, TNF-α, IFN-γ) макрофагами. Антитела против TNF-α частично угнетали 
противоопухолевую активность культурального супернатанта макрофагов, инкубированных с липополисахаридом, но не с 
желатином. Желатин индуцировал противоопухолевую активность макрофагов как C3H/HeJ мышей, так и мышей C3H/
HeN, в то время как липополисахарид влиял только на макрофаги C3H/HeN мышей. Макрофаги, стимулированные in vitro, 
показывали противоопухолевую активность in vivo. Более того, желатин стимулировал клетки перитонеального экссудата 
in vivo при одновременном подкожном введении. Выводы: желатин свиной кожи индуцирует противоопухолевую активность 
макрофагов у мышей, причем более эффективно, чем липополисахарид E. coli. Механизм действия желатина отличается от 
механизма действия липополисахарида и остается пока невыясненным до конца.
Ключевые слова: желатин свиной кожи, макрофаги, цитотоксичность.
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